Struc­tu­ral analyses
Tog­e­ther with pharmafakt, you can deter­mi­ne the mar­ket and pro­duct con­cen­tra­ti­ons in any way within the cons­traints of data pro­tec­tion law and ascer­tain pre­cise infor­ma­ti­on about your cur­rent mar­ket posi­tio­ning. (Details)

Tar­get groups validations
Tar­get groups vali­da­ti­ons make it pos­si­ble to map, based on anony­mous pre­scrip­ti­on data, drug and mar­ket con­cen­tra­ti­on and to com­bi­ne it with ano­ther tar­get group infor­ma­ti­on. The result is valid and indi­vi­du­al­ly tar­get group clus­ters with the hig­hest expl­ana­to­ry power are con­fi­gu­red. (Details)

Multi-channel-monitoring
We moni­tor your sales-force-effectiveness and the effec­ti­ve­ness of patient-centred care pro­gram­mes. (Details)

Defi­ni­ti­ons of tar­get groups
We use mul­ti­va­ria­te ana­ly­sis methods to ascer­tain tar­get groups across the coun­try. (Details)

Field struc­tu­re optimization
To adapt to chan­ging field ser­vice struc­tures, we sup­port you in opti­mi­zing exis­ting or defi­ne new ter­ri­to­ri­al structures.

Moni­to­ring
We can track pre­scrib­ing figu­res over time both in the event of pro­duct laun­ches and for the pur­po­ses of mea­su­ring effi­ci­en­cy. Com­pli­ance, pati­ent flows and tre­at­ment dura­ti­ons can be recor­ded and ana­ly­sed using tre­at­ment ana­ly­ses. (Details)

Tre­at­ment analyses
Com­pli­ance, pati­ent flows and tre­at­ment dura­ti­ons can be recor­ded and ana­ly­sed using tre­at­ment ana­ly­ses. (Details)

We call this needs-based and customer-oriented studies.